Literature DB >> 20036577

Gene modulation and immunoregulatory roles of interferon gamma.

Banishree Saha1, S Jyothi Prasanna, Bhagawat Chandrasekar, Dipankar Nandi.   

Abstract

Interferon-gamma (IFNgamma) is a central regulator of the immune response and signals via the Janus Activated Kinase (JAK)-Signal Transducer and Activator of Transcription (STAT) pathway. Phosphorylated STAT1 homodimers translocate to the nucleus, bind to Gamma Activating Sequence (GAS) and recruit additional factors to modulate gene expression. A bioinformatics analysis revealed that greater number of putative promoters of immune related genes and also those not directly involved in immunity contain GAS compared to response elements (RE) for Interferon Regulatory Factor (IRF)1, Nuclear factor kappa B (NFkappaB) and Activator Protein (AP)1. GAS is present in putative promoters of well known IFNgamma-induced genes, IRF1, GBP1, CXCL10, and other genes identified were TLR3, VCAM1, CASP4, etc. Analysis of three microarray studies revealed that the expression of a subset of only GAS containing immune genes were modulated by IFNgamma. As a significant correlation exists between GAS containing immune genes and IFNgamma-regulated gene expression, this strategy may identify novel IFNgamma-responsive immune genes. This analysis is integrated with the literature on the roles of IFNgamma in mediating a plethora of functions: anti-microbial responses, antigen processing, inflammation, growth suppression, cell death, tumor immunity and autoimmunity. Overall, this review summarizes our present knowledge on IFNgamma mediated signaling and functions. 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20036577     DOI: 10.1016/j.cyto.2009.11.021

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  128 in total

Review 1.  Interferons in autoimmune and inflammatory diseases: regulation and roles.

Authors:  Divaker Choubey; Kamal D Moudgil
Journal:  J Interferon Cytokine Res       Date:  2011-12       Impact factor: 2.607

2.  Contribution of a TANK-binding kinase 1-interferon (IFN) regulatory factor 7 pathway to IFN-γ-induced gene expression.

Authors:  Matthias Farlik; Birgit Rapp; Isabelle Marie; David E Levy; Amanda M Jamieson; Thomas Decker
Journal:  Mol Cell Biol       Date:  2012-01-17       Impact factor: 4.272

3.  Interferon-γ biphasically regulates angiotensinogen expression via a JAK-STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells.

Authors:  Ryousuke Satou; Kayoko Miyata; Romer A Gonzalez-Villalobos; Julie R Ingelfinger; L Gabriel Navar; Hiroyuki Kobori
Journal:  FASEB J       Date:  2012-02-01       Impact factor: 5.191

4.  SOCS1 prevents graft arteriosclerosis by preserving endothelial cell function.

Authors:  Lingfeng Qin; Qunhua Huang; Haifeng Zhang; Renjing Liu; George Tellides; Wang Min; Luyang Yu
Journal:  J Am Coll Cardiol       Date:  2013-08-28       Impact factor: 24.094

5.  Tumor-cell co-culture induced alternative activation of macrophages is modulated by interferons in vitro.

Authors:  Ulrike Carolin Müller-Quernheim; Lars Potthast; Joachim Müller-Quernheim; Gernot Zissel
Journal:  J Interferon Cytokine Res       Date:  2012-01-26       Impact factor: 2.607

Review 6.  Interferons: Success in anti-viral immunotherapy.

Authors:  Fan-ching Lin; Howard A Young
Journal:  Cytokine Growth Factor Rev       Date:  2014-07-29       Impact factor: 7.638

Review 7.  Immunomodulation of autoimmune arthritis by pro-inflammatory cytokines.

Authors:  Eugene Y Kim; Kamal D Moudgil
Journal:  Cytokine       Date:  2017-04-25       Impact factor: 3.861

8.  IFN-γ-inducible antiviral responses require ULK1-mediated activation of MLK3 and ERK5.

Authors:  Diana Saleiro; Gavin T Blyth; Ewa M Kosciuczuk; Patrick A Ozark; Beata Majchrzak-Kita; Ahmet D Arslan; Mariafausta Fischietti; Neha K Reddy; Curt M Horvath; Roger J Davis; Eleanor N Fish; Leonidas C Platanias
Journal:  Sci Signal       Date:  2018-11-20       Impact factor: 8.192

9.  Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma.

Authors:  De-Ke Jiang; Jielin Sun; Guangwen Cao; Yao Liu; Dongxin Lin; Yu-Zhen Gao; Wei-Hua Ren; Xi-Dai Long; Hongxing Zhang; Xiao-Pin Ma; Zhong Wang; Wei Jiang; Tao-Yang Chen; Yong Gao; Liang-Dan Sun; Ji-Rong Long; Hui-Xing Huang; Dan Wang; Hongjie Yu; Pengyin Zhang; Li-Sha Tang; Bo Peng; Hao Cai; Ting-Ting Liu; Ping Zhou; Fang Liu; Xiaoling Lin; Sha Tao; Bo Wan; He-Xi Ge Sai-Yin; Lun-Xiu Qin; Jianhua Yin; Li Liu; Chen Wu; Yan Pei; Yuan-Feng Zhou; Yun Zhai; Pei-Xin Lu; Aihua Tan; Xian-Bo Zuo; Jia Fan; Jiang Chang; Xiaoli Gu; Neng-Jin Wang; Yang Li; Yin-Kun Liu; Kan Zhai; Hongwei Zhang; Zhibin Hu; Jun Liu; Qing Yi; Yongbing Xiang; Rong Shi; Qiang Ding; Wei Zheng; Xiao-Ou Shu; Zengnan Mo; Yin Yao Shugart; Xue-Jun Zhang; Gangqiao Zhou; Hongbing Shen; S Lilly Zheng; Jianfeng Xu; Long Yu
Journal:  Nat Genet       Date:  2012-12-16       Impact factor: 38.330

10.  Human monocytes have increased IFN-γ-mediated IL-15 production with age alongside altered IFN-γ receptor signaling.

Authors:  Naeun Lee; Min Sun Shin; Ki Soo Kang; Seung-Ah Yoo; Subhasis Mohanty; Ruth R Montgomery; Albert C Shaw; Insoo Kang
Journal:  Clin Immunol       Date:  2014-03-19       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.